2001
DOI: 10.1080/003655201750153359
|View full text |Cite
|
Sign up to set email alerts
|

Sensitivity of Serum Tissue Transglutaminase Antibodies for Endomysial Antibody Positive and Negative Coeliac Disease

Abstract: Although the ELISA tTGA assay is more convenient than EmA testing, it offers no advantages in sensitivity or specificity if used in isolation. However, incomplete concordance between EmA and tTGA positivity means that combination screening with both assays offers higher sensitivity, as almost a third of patients have only one antibody. As some coeliac patients with normal serum IgA are negative for both antibodies, biopsies should still be performed in seronegative individuals deemed at high risk for coeliac d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
20
1
1

Year Published

2003
2003
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(25 citation statements)
references
References 14 publications
3
20
1
1
Order By: Relevance
“…The first aspect seems to be fully confirmed by recent reviews showing that serum IgA EmA antibodies have 90%-100% sensitivity and 95%-100% specificity and that IgA anti-tTG antibodies show very similar values (14,15 ), mainly obtained with the second-generation, human anti-tTG assays (9,16 ). However, the presence of positive serum antibodies has been shown to correlate with the degree of villous atrophy, and CD patients with less severe histologic damage can be seronegative for CD (17)(18)(19)(20). It has been demonstrated previously that the culture medium of intestinal biopsy specimens from some of these CD patients showed positive EmA antibodies, and this positivity can be useful for CD diagnosis in patients with minimal intestinal histologic lesions (8,21 ).…”
Section: Discussionmentioning
confidence: 79%
See 1 more Smart Citation
“…The first aspect seems to be fully confirmed by recent reviews showing that serum IgA EmA antibodies have 90%-100% sensitivity and 95%-100% specificity and that IgA anti-tTG antibodies show very similar values (14,15 ), mainly obtained with the second-generation, human anti-tTG assays (9,16 ). However, the presence of positive serum antibodies has been shown to correlate with the degree of villous atrophy, and CD patients with less severe histologic damage can be seronegative for CD (17)(18)(19)(20). It has been demonstrated previously that the culture medium of intestinal biopsy specimens from some of these CD patients showed positive EmA antibodies, and this positivity can be useful for CD diagnosis in patients with minimal intestinal histologic lesions (8,21 ).…”
Section: Discussionmentioning
confidence: 79%
“…Histologic findings and the clinical follow-up confirmed that 162 of the 166 patients positive for serum EmA and/or anti-TG antibodies had CD. The other 4 patients (1 positive for EmA and anti-tTG antibodies, and 3 positive only for anti-tTG antibodies) in whom CD diagnosis was excluded showed a normal duodenal histology, with a villi/crypts ratio Ͼ3.5 and Ͻ30 IELs/100 epithelial cells (range, [12][13][14][15][16][17][18][19][20].…”
Section: Final Diagnoses In the Study Groupmentioning
confidence: 99%
“…Antibodies to endomysium (IgA endomysium antibody, EMA) can be measured in serum via indirect immunofluoresence to provide a serological test for cluster of differentiation which has been shown to be highly sensitive and specific, with values for both parameters exceeding 95% in most studies (13). An alternative approach using an enzyme linked immunoabsorbent assay measuring IgA tissue transglutaminase antibody (tTGA) levels has comparable sensitivity and specificity, however, incomplete concordance between the two tests has led some authors to suggest combination screening (14). By contrast, the previously widely used antigliadin tests have been shown to have relatively poor sensitivity and specificity.…”
Section: Introductionmentioning
confidence: 99%
“…5 It is well recognized that the combined use of the two antibodies (EMA and TTG) provides greater sensitivity in diagnosing celiac disease, since almost one third of the patients present reactivity for only one of the two antibodies. 23 However, from a practical standpoint, the sensitivity of commercial assays may vary and does not necessarily represent what is described in the literature, especially in subjects with major villous atrophy. An association between celiac disease and autoimmune thyroiditis has been reported worldwide, especially in Europe.…”
Section: Discussionmentioning
confidence: 99%